Showing results (2401-2410 of 2,591) with videos related to

Sort By:
Pageof 260
Molecular Oncology|January 20, 2017
T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancerJian-Feng Liu, Si-Rui Ma, Liang Mao, et al.
Molecular Oncology|March 3, 2017
Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52Jugal Bharat Joshi, Divya Patel, Derrick J Morton, et al.
Molecular Oncology|February 2, 2017
Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancerRohina Rubicz, Shanshan Zhao, Jonathan L Wright, et al.
Molecular Oncology|February 2, 2017
Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancerAnn Rita Halvorsen, Åslaug Helland, Pavel Gromov, et al.
Molecular Oncology|March 18, 2017
MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenanceXuan Gao, Guangming Chen, Chenxi Gao, et al.
Molecular Oncology|March 18, 2017
Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitorsRyan C Chai, Jessica L Vieusseux, Benjamin J Lang, et al.
Molecular Oncology|January 31, 2017
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancerKaren Hanrahan, Amanda O'Neill, Maria Prencipe, et al.
Molecular Oncology|March 27, 2019
Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinomaNamhee Yu, Seunghui Yong, Hong Kwan Kim, et al.
Molecular Oncology|January 14, 2017
Circulating and disseminated tumor cells: harbingers or initiators of metastasis?Arko Dasgupta, Andrea R Lim, Cyrus M Ghajar
Molecular Oncology|January 14, 2017
Determinants of metastatic competency in colorectal cancerDaniele V F Tauriello, Alexandre Calon, Enza Lonardo, et al.
Pageof 260